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Background: Understanding the pattern of recovery and expected rate of change after shoulder arthroplasty is
helpful to clinicians and patients for setting realistic expectations and goals. The purpose of this study was to
describe the pattern of recovery over a 2-year period for patients receiving either a Total Shoulder Arthroplasty
(TSA) or Humeral Head Replacement (HHR).
Methods: This was a secondary analysis of prospectively collected data of patients who had undergone TSA or
HHR and were followed for up to 2 years. Patients were seen prior to surgery and at 6 months, one year and two
years after surgery and completed the American Shoulder and Elbow Surgeon’s (ASES) questionnaire, Relative
Constant Murley score (RCMS) and underwent range of motion and strength assessment.
Results: Data of 134 patients who had surgery from April 2001 to July 2011 were used for analysis. One hundred
and eight patients underwent TSA (81%) and 26 (19%) had HHR. Both surgeries were associated with a statistically
significant improvement in physical symptoms, ASES, RCMS, range of motion and strength (p <0.0001). The greatest
change for all outcomes occurred within the first 6-months of surgery. Improvement in ASES, RCMS continued up
to 12-months and then plateaued. Improvement in physical symptoms leveled off at 6-months in the HHR group
but continued up to 12-months in the TSR group. Strength showed improvement in both groups up to 24-months
post-surgery.
Conclusion: Both TSA and HHR groups showed a statistically significant improvement in perceived disability, range
of motion and strength over two years with the greatest improvement made by 6 months. The recovery profiles for
the surgeries showed different patterns.
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Primary osteoarthritis of the glenohumeral joint is charac-
terized by loss of the articular cartilage producing joint
space narrowing, subchondral sclerosis and osteophyte
formation. Surgical management is considered when con-
servative treatment such as rehabilitation, intra-articular
corticosteroid injection, anti-inflammatory medication and
analgesics fail to provide relief.
Traditionally, Total Shoulder Arthroplasty (TSA) is
the treatment of choice for primary and posttraumatic
osteoarthritis and also some inflammatory conditions of* Correspondence: helen.razmjou@sunnybrook.ca
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Humeral Head Replacement (HHR) has also been utilized
for primary osteoarthritis, but is more often indicated for
patients with inflammatory arthritis with severe rotator
cuff deficiency, cuff tear arthropathy, proximal humeral
fractures, osteonecrosis of the humeral head with a pre-
served glenoid, or in the presence of insufficient glenoid
bone stock [1]. The literature shows that the majority of
patients improve significantly with respect to pain and
range of motion following TSA [2,3]. The outcome of
HHR seems to be less predictable [4-6] partly due to rota-
tor cuff or glenoid bone deficiency. To eliminate the im-
pact of cuff pathology or glenoid co-morbidity, a number
of randomized clinical trials with homogenized samples
(patients with primary osteoarthritis) have been conducted
to better examine the difference in outcome of these twol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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arthroplasty provided better functional outcomes than
hemiarthroplasty for patients with primary osteoarthritis
of the shoulder.
Overall, the inferior outcome of HHR is known and
partly justified due to more extensive pathology of the
shoulder in this population. However, the limitation of
the available research is lack of information on import-
ant time points which helps to predict when patients
reach their maximal recovery as measured by patient re-
ported measures of pain and disability or functional abil-
ities including range of motion and strength.
We are not aware of any studies that have determined
the specific time point of maximal recovery following
shoulder arthroplasty procedures. Understanding the pat-
tern of change would help clinicians to communicate the
expected results of surgery and time frame for reaching
maximal recovery to their patients. It is also important
that studies are controlled for sex and age as aging affects
the overall function and females have shown less improve-
ment after shoulder surgery related to rotator cuff path-
ology [8] and lower extremity arthroplasty [9-11].
The purpose of this study was to describe the pattern
of recovery over a 2-year period for patients receiving ei-
ther a Total Shoulder Arthroplasty (TSA) or Humeral
Head Replacement (HHR).Methods
This was a secondary analysis of prospectively collected
data of patients with advanced osteoarthritis of the gle-
nohumeral joint who had undergone TSA or HHR and
had participated in previous formal studies and were
followed up for up to 2 years. This study has adhered to
the STROBE guidelines for observational studies and
has received ethics approval from the Research Ethics
Board of the Sunnybrook Health Sciences Centre.Subjects
The inclusion criteria included age greater than 18 years, a
diagnosis of advanced primary osteoarthritis or inflamma-
tory arthritis with or without rotator cuff pathology that
had not responded to conservative treatment. The exclu-
sion criteria included inability to speak or read English,
evidence of infection, underlying metabolic disease, avas-
cular necrosis, or capsulorraphy arthropathy. Patients with
primary osteoarthritis of the glenohumeral joint and an in-
tact rotator cuff underwent TSA. Those with humeral
fractures and a normal glenoid articular surface or with se-
vere glenoid deficiency with or without cuff tear arthropa-
thy received HHR. In addition, younger patients and those
with significant medical co-morbidities underwent HHR,
rather than reverse arthroplasty, as the reverse prosthesis
may not be sufficiently durable in younger age group andmay have higher complication rate in the presence of
other medical conditions.
All patients followed a standardized rehabilitation
protocol. A sling was used for two weeks with imme-
diate active assisted mobilization following surgery.
Sub-maximal isometric exercises started at four weeks
post-operatively. Active exercises started at 6 weeks in
lying progressing to upright position at 7 weeks. Resis-
tive exercises involving theraband started at 8-10 weeks.
Exercises related to internal rotation followed the other
directions of movement with a 4-week delay to avoid
strain on subscapularis.
Outcome measures
Two patient-oriented outcome measures and a record of
physical symptoms were obtained 2-3 weeks before surgery
and on clinic visits at 6, 12, and 24 months after surgery.
The outcome measures were the American Shoulder and
Elbow Surgeon’s (ASES) assessment form [12] and the
Relative Constant Murley score (RCMS) [13]. The ASES is
a 100-point scale, 50 points of which are derived from pa-
tient self-report of pain on a visual analog scale and 50
points of which are computed from a formula using the cu-
mulative score of 10 activities of daily living derived using a
four-point ordinal scale. The Constant Murley score is a
combined measure, containing a patient reported compo-
nent (35%) and the clinical assessment of range of motion
and strength (65%). The absolute score is then converted to
the relative score by accounting for age and sex-related dif-
ferences. Higher scores on the ASES and RCMS indicate
less disability. Both measures have established validity and
reliability in patients with glenohumeral osteoarthritis
[14,15]. Physical symptoms were measured by the physical
symptoms domain of the Western Ontario Osteoarthritis
Shoulder (WOOS) Index [16]. Symptoms captured pain
with movement, nagging constant pain, weakness, stiffness,
grinding and impact of weather changes on pain. The score
of the physical symptoms domain varied from 0 as no pain
to 600 as the maximal pain and discomfort. Performance
measures included active range of motion (ROM) in 3 di-
rections (flexion, abduction, external rotation in neutral,
and hand behind back) and strength in scapular plane ele-
vation. Strength was measured with a simple tensiometer
with the shoulder at 90 degrees of elevation in the plane of
the scapula and the elbow extended while the clinician
pulled down on the tensiometer. The maximum painfree
force that the patient could resist for 5 seconds as the
examiner pulled down on the device was measured. In the
case of pain while holding the position, strength was given
a score of zero.
Statistical analyses
Descriptive analyses of patients’ characteristics and out-
come measures’ summary scores were performed. This
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We applied Generalized Estimating Equations (GEE) to
test for differences in the surgical groups’ change trajector-
ies for each outcome measure. GEE fit population aver-
aged panel data models. Complete data for a given
outcome measure at all time-points is not required for a
patient to be included in the analysis. Dependent variables
were the outcome measures assessed at multiple time-
points. The independent variables were surgical group
(levels were TSA and HHR) and measurement occasion
(levels were pre-surgery, 6, 12, 24-months); covariates
were gender and age. All analyses were conducted using
STATA version 13.0 (STATACorp, College Station, TX).
Results
Data of 149 patients were reviewed. Three patients died
of causes not related to shoulder arthroplasty. Twelve
patients (6 in the TSA and 6 in the HHR group) had
missed two consecutive assessments, one being the 2 year
follow-up, and were not included in the analysis. The
baseline characteristics (age, physical symptoms, ASES,
RCMS) of these 12 patients were not different than the
remaining. Data of 134 patients (73 females (54%), 61
males (46%), mean age = 67 years, SD: 9) who had sur-
gery from April 2001 to July 2011 were used for final
analysis. One hundred and eight patients underwent
TSA (81%) and 26 (19%) had HHR (Table 1). The diag-
noses were primary osteoarthritis (96%) and inflamma-
tory arthritis (4%) with intact rotator cuff in the TSA
group. The Neer II prosthesis was used in 18 patients
with 49 patients receiving the Bigliani-Flatow (BF) pros-
thesis and 41 receiving the Total Evolutive Shoulder Sys-
tem (TESS). Seventy percent (18) of the HHR group had
primary osteoarthritis with deficient glenoid bone. Four
patients had inflammatory arthritis (15%). There wereTable 1 Baseline data for the Outcome Measures
HHR TSR
Variable N Mean SD N Mean SD
ASES 26 27.08 17.62 108 34.37 15.97
ACMS 26 20.60 11.4 106 21.10 11.50
Pain* 26 1.70 2.80 108 1.50 2.50
ADL* 26 6.1 3.2 108 6.9 2.7
ROM* 26 9.20 6.50 106 8.8 6.1
Strength*§ 26 3.60 4.22 108 4.02 3.83
RCMS (%) 26 27.48 14.85 106 27.83 14.32
PS 26 457.81 101.04 108 410.04 107.75
Flex 26 65.88 29.70 108 63.89 27.26
Abd 26 50.88 27.13 108 44.02 21.69
Ext Rot 26 14.23 13.39 108 12.64 10.97
*:Components of the Constant Murley score.
§: In Pounds.three humeral head fractures (11%) and one cuff tear ar-
thropathy (4%). The patient with cuff tear arthropathy
was an 80 year old female who had undergone a rotator
cuff repair five year previously and was not a good can-
didate for reverse arthroplasty due to other medical co-
morbidities. The majority of the patients in the HHR
group received the BF prosthesis (22, 73%) with three
TESS prostheses and one Dupuy Global CTA Advantage
system. Patients in the TSA group were not different
than patients in the HHR group with respect to age, sex,
or mechanism of injury (p > 0.05).
Table 2 provides a summary of the outcome measure
mean values for the TSA and HHR groups for each as-
sessment occasion. All outcome measures reflected large
and statistically significant improvements at 2 years.
Figure 1 and Figure 2 display the TSA and HHR change
profiles for the RCMS and ASES respectively. The great-
est change for all outcomes occurred within the first
6-months of surgery. Improvement continued up to 12-
months and then plateaued in all measures except phys-
ical symptoms, external rotation and strength which
showed a different pattern. Figure 3 displays the TSA
and HHR change profiles for the physical symptoms. For
patients receiving TSA, improvement occurred up to 12-
months and then plateaued. For patients receiving HHR,
improvement leveled off at 6-months and slightly de-
clined thereafter. Figure 4 shows the change profile for
strength which shows improvement in both groups up
to 24-months post-surgery.
Discussion
In the present study, we found that both TSA and HHR
groups improved in their physical symptoms, disability
level and range of motion over time. However, the HHR
group reported overall higher disability as measured by
the ASES, RCMS, and symptoms. As apparent in the fig-
ures, different patterns of recovery were observed in
these measures.
Recovery of external rotation was similar between
groups. Improvement of external rotation in both
groups may be related to change in biomechanics of
the replaced joint regardless of type of procedure. It has
been shown that an anatomical reconstruction of the hu-
meral head can restore the physiological motions and lim-
ited eccentric loading of the glenoid, which may explain
more improvement in external rotation than elevation [17].
Although the rate of change was different between
HHR and TSA, the most significant recovery of disabil-
ity, physical symptoms and range of motion was made
by 6 months. In terms of the ASES and RCMS outcome
measure scores and range of motion, recovery continued
to 12 months and then began to plateau. This was also
the case for the TSA group with respect to the change
profile for the physical symptoms. In contrast, physical
Table 2 Means of the outcome measures at specific assessment occasions
Outcome measure Pre-surgery (95% CI) 6-months (95% CI) 12-months (95% CI) 24-months (95% CI)
ASES
HHR 27 (21, 34) 63 (56, 70) 62 (55, 69) 63 (55, 70)
TSA 34 (31, 38) 73 (70, 77) 80 (77, 83) 80 (77, 84)
RCMS
HHR 27 (19, 35) 60 (52, 69) 64 (56, 72) 63 (54, 73)
TSA 28 (24, 32) 72 (68, 76) 82 (78, 87) 86 (82, 90)
Physical Symptoms
HHR 458 (413, 503) 175 (129, 221) 180 (135, 226) 253 (199, 306)
TSA 410 (388, 432) 128 (106, 150) 100 (77, 122) 98 (76, 121)
Strength
HHR 3.6 (2.1, 5.0) 5.4 (3.9, 6.9) 6.4 (4.9, 7.8) 6.8 (5.1, 8.5)
TSA 4.0 (3.3, 4.7) 6.7 (6.0, 7.4) 8.5 (7.8, 9.2) 9.6 (8.8, 10.3)
Flexion
HHR 66 (54, 79) 98 (85, 111) 104 (91, 117) 107 (93, 121)
TSA 64 (57, 70) 116 (110, 123) 130 (123, 136) 131 (125, 137)
Abduction
HHR 51 (38, 64) 83 (70, 97) 93 (80, 107) 84 (71, 98)
TSA 44 (38, 51) 101 (94, 107) 115 (109, 122) 119 (112, 125)
Ext. Rot.
HHR 14 (7.9, 20) 40 (33, 46) 40 (34, 46) 42 (35, 49)
TSA 13 (10, 16) 42 (39, 45) 47 (44, 50) 47 (44, 50)
Change over time (2-year scores - pre-op scores) was significant for TSA and HHR groups for all measures at p < 0.0001.
Figure 1 Relative Constant Murley Score change profile.
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Figure 2 ASES Score change profile.
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and then began to decline. A different pattern of recov-
ery was noted for strength which showed continued im-
provement until 24 months post surgery.
Our results are consistent with the literature which indi-
cates an overall improvement in pain and disability follow-
ing shoulder arthroplasty [2-7,18-23]. The contribution of
our study is exploring the typical trajectory of recovery
after each procedure. This information is useful to clini-
cians as it enables them to communicate the expected
point of maximal recovery or plateau to their patients
more accurately. It is also of importance to patients as itFigure 3 Physical symptom change profile.helps them to have realistic expectations and set appropri-
ate goals throughout their recovery. More specifically, pa-
tients who undergo HHR may benefit from knowing that
although elevation may have a slower and less significant
improvement, external rotation, and overall disability will
show improvement up to one year with strength gains of
up to two years.
Limitations
Despite consistency between our results and the avail-
able literature, the present study involved secondary ana-
lysis of prospectively collected data of patients operated
Figure 4 Strength change profile.
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which may limit generalizability of our findings.
In the present study, most of the recovery happened in
the first 6 months. Although shoulder joint replacement
is a major surgery with a prolonged recovery, future
work might include more sampling prior to the 6-month
time period.Conclusion
Our study showed a statistically significant improvement
in all patient reported and performance measures re-
gardless of the type of arthroplasty. The greatest change
for all outcomes measured occurred within the first 6-
months of surgery. In the HHR group, despite a slight
decline in physical symptoms after 6 months, there was
a significant overall improvement from the pre-operative
level. Strength continued to improve up to 24 months
post surgery. The pattern of recovery differed by out-
come measure and type of procedure. Knowledge of
these recovery patterns will help clinicians direct appro-
priate rehabilitation and patients set more realistic goals
and expectations.Abbreviations
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